Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.
Xue M, Li T, Wang Y, Chang Y, Cheng Y, Lu Y, Liu X, Xu L, Li X, Yu X, Sun B, Chen L.
Xue M, et al. Among authors: li t, li x.
Clin Sci (Lond). 2019 Aug 2;133(15):1705-1720. doi: 10.1042/CS20190585. Print 2019 Aug 15.
Clin Sci (Lond). 2019.
PMID: 31337673